Andrew L. Wylie

Andrew L. Wylie, MBA, is a seasoned sales professional currently serving as a Clinical Sales Specialist at Kiniksa Pharmaceuticals since August 2022, where responsibilities include the education and promotion of Arcalyst (rilonacept) across major Manhattan healthcare facilities. Notable achievements include ranking #8 nationally among 90 clinical sales specialists in 2024 and exceeding performance expectations with impressive sales metrics. Prior to Kiniksa, Andrew Wylie held key roles at Melinta Therapeutics, Janssen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Hospira, Sanofi, and Pfizer, accumulating extensive experience in pharmaceutical sales across diverse specialties. Academic credentials include an MBA in Pharmaceutical Marketing and Management from the New York Institute of Technology and a B.A. in Government from Franklin & Marshall College.